Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bausch + Lomb Corporation (BLCO)
NYSE:BLCO
RESEARCH TOOLSreports
Holding BLCO?
Track your performance easily
BLCO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$13.16 - $21.69
Previous Close$18
Volume401.50K
Average Volume (3M)554.45K
Market Cap
$6.32B
Enterprise Value$10.69B
Total Cash (Recent Filing)$329.00M
Total Debt (Recent Filing)$4.63B
Price to Earnings (P/E)―
Beta0.86
Next Earnings
Feb 19, 2025EPS Estimate
$0.24Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.05
Shares Outstanding352,164,025
10 Day Avg. Volume5,675,269
30 Day Avg. Volume554,454
Standard Deviation0.09
R-Squared0.05
Alpha0.00326
Financial Highlights & Ratios
Price to Book (P/B)0.96
Price to Sales (P/S)1.35
Price to Cash Flow (P/CF)10.30
P/FCF Ratio8.20
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.37
Enterprise Value/Gross Profit4.27
Enterprise Value/Ebitda15.87
Forecast
1Y Price Target
$21.29Price Target Upside18.28% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering10
Bausch + Lomb Corporation News
Bulls Say, Bears Say
Bulls Say
Product PerformanceMiebo and Xiidra sales exceeded expectations, indicating strong product performance and growth potential.
Revenue GrowthBausch + Lomb reported a total revenue of $1,196M, representing 19% YoY growth, and beat revenue projections.
Sales GuidanceManagement raised the 2024 revenue guidance, indicating confidence in future performance.
Bears Say
Inflation Reduction Act ImpactXiidra may face incremental headwinds due to potential impacts from the Inflation Reduction Act and changes in payor coverage.
Private Equity TakeoutPrivate equity takeout seems less likely following the report that Blackstone backed out of a potential acquisition of BLCO over price.
Spin-off And SeparationBLCO shares have largely been under pressure since its IPO as investor concerns on a potential spin have outweighed any positive fundamental trends.
---
Ownership Overview
0.50% Insiders
0.32% Mutual Funds
8.42% Other Institutional Investors
90.66% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
BLCO FAQ
What was Bausch + Lomb Corporation’s price range in the past 12 months?
Bausch + Lomb Corporation lowest stock price was $13.16 and its highest was $21.69 in the past 12 months.
What is Bausch + Lomb Corporation’s market cap?
Currently, no data Available
When is Bausch + Lomb Corporation’s upcoming earnings report date?
Bausch + Lomb Corporation’s upcoming earnings report date is Feb 19, 2025 which is in 59 days.
How were Bausch + Lomb Corporation’s earnings last quarter?
Bausch + Lomb Corporation released its earnings results on Oct 30, 2024. The company reported $0.17 earnings per share for the quarter, beating the consensus estimate of $0.157 by $0.013.
Is Bausch + Lomb Corporation overvalued?
According to Wall Street analysts Bausch + Lomb Corporation’s price is currently Undervalued.
Does Bausch + Lomb Corporation pay dividends?
Bausch + Lomb Corporation does not currently pay dividends.
What is Bausch + Lomb Corporation’s EPS estimate?
Bausch + Lomb Corporation’s EPS estimate is $0.24.
How many shares outstanding does Bausch + Lomb Corporation have?
Bausch + Lomb Corporation has 352,164,030 shares outstanding.
What happened to Bausch + Lomb Corporation’s price movement after its last earnings report?
Bausch + Lomb Corporation reported an EPS of $0.17 in its last earnings report, beating expectations of $0.157. Following the earnings report the stock price went down -1.541%.
Which hedge fund is a major shareholder of Bausch + Lomb Corporation?
Among the largest hedge funds holding Bausch + Lomb Corporation’s share is Maple Rock Capital Partners Inc.. It holds Bausch + Lomb Corporation’s shares valued at 70M.
---
Bausch + Lomb Corporation Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$21.29 (18.28% Upside)
$21.29 (18.28% Upside)
Blogger Sentiment
Bullish
BLCO Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 820.7K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.9%
Last 30 Days ▼ 3.3%
Last 30 Days ▼ 3.3%
Technicals
SMA
Positive
20 days / 200 days
Momentum
17.57%
12-Months-Change
Fundamentals
Return on Equity
-5.49%
Trailing 12-Months
Asset Growth
3.42%
Trailing 12-Months
Company Description
Bausch + Lomb Corporation
Bausch & Lomb Corp is a global eye health company dedicated towards protecting and enhancing the gift of sight for millions of people around the world. It holds portfolio of more than 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments.
---
BLCO Company Deck
---
BLCO Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call demonstrated strong revenue growth across all segments, with significant investments in new product launches and digital initiatives. However, there were notable challenges in the U.S. consumer market and concerns about the future impact of the Inflation Reduction Act on pharmaceutical sales.Read More>---
BLCO Stock 12 Month Forecast
Average Price Target
$21.29
▲(18.28% Upside)
Technical Analysis
Best Analysts Covering BLCO
1 Year
1 Year Success Rate
12/17 ratings generated profit
1 Year Average Return
+8.92%
assigned a buy rating 2 months ago
Copying Douglas Miehm's trades and holding each position for 1 Year would result in 70.59% of your transactions generating a profit, with an average return of +8.92% per trade.
---